Narcís Saubi

Dr. Narcís Saubi

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1993 in Archives of Biochemistry and Biophysics
Verified
Journal Article
Closed access
MBM D Boleda
M D Boleda
NSNarcís Saubi
Narcís Saubi
JFJaume Farrés
Jaume Farrés
XPX. Pares
X. Pares

1 April 1999 in Veterinary Microbiology
Verified
Journal Article
Closed access
GAG.M Allan
G.M Allan
FNF Mc Neilly
F Mc Neilly
BMB.M Meehan
B.M Meehan
SKS Kennedy
S Kennedy
DMD.P Mackie
D.P Mackie
CCC.E Charreyre
C.E Charreyre

1 September 2006 in The Veterinary Journal
Verified
Journal Article
Closed access
JMJaime Maldonado
Jaime Maldonado
KRKristien Van Reeth
Kristien Van Reeth
PRPere Riera
Pere Riera
MSMarta Sitjà
Marta Sitjà
NSNarcís Saubi
Narcís Saubi
CACarlos Artigas
Carlos Artigas

25 May 1992 in FEBS Letters
Verified
Journal Article
Open access
PDF file
XPXavier Parés
Xavier Parés
ECElla Cederlund
Ella Cederlund
AMAlberto Moreno
Alberto Moreno
NSNarcís Saubi
Narcís Saubi
JHJan-Olov Hóóg
Jan-Olov Hóóg
HJHans Jörnvall
Hans Jörnvall
Human gastric alcohol dehydrogenase (σσ‐ADH) was submitted to peptide analysis at picomole scale. A total of 72 positions were determined in the protein chain, providing information on three aspects of alcohol dehydrogenase structures in general. First, the data establish the presence of a unique class of the enzyme, now confirmed as class IV, expressed in gastric tissue and separate from another novel class. now termed class V. Second, the class IV gastric enzyme has active site relationships compatible with an ethanol‐active, zinc‐containing alcohol dehydrogenase. Third, this enzyme class is of the variable type, like that for the ‘variable’, classical liver alcohol dehydrogenase of class I, and in contrast to that for the ‘constant’ class III enzyme. Known human alcohol dehydrogenase structures now prove the presence of at least seven human genes for the enzyme and nine for the whole protein family.

1 July 2003 in Vaccine
Verified
Journal Article
Closed access
JMJorge Luis Martinez-Torrecuadrada
Jorge Luis Martinez-Torrecuadrada
NSNarcís Saubi
Narcís Saubi
APAlbert Pagès-Manté
Albert Pagès-Manté
JCJose Caston
Jose Caston
EEEnric Espuña
Enric Espuña
JCJ. Ignacio Casal
J. Ignacio Casal

4 December 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
RPR. Perello
R. Perello
AVAndrea Vergara
Andrea Vergara
EME. Monclus
E. Monclus
SJSònia Jiménez
Sònia Jiménez
MMMarta Montero
Marta Montero
MMmaria angeles Marcos
maria angeles Marcos
Background: Cytomegalovirus infection dramatically decreased with the introduction of antiretroviral therapy. Whether incidence, clinical characteristics and prognosis of cytomegalovirus in HIV infected patients, has changed over time is. scarcely known. Methods: Retrospective single-center study. Patients included in this study were all HIV infected patients that went to our center for any disease, and were diagnosed with cytomegalovirus, during the period 2004–2015. epidemiological, clinical and laboratory patients variables were collected in a clinical database. Clinical characteristics, incidence of cytomegalovirus and predictors of mortality during the study were assessed. Results were considered statistically significant when p < 0.05. All statistical analyses were calculated by SPSS version 20.0 (Chicago, IL,USA). Results: Fifty-six cases of cytomegalovirus infection, in HIV infected patients were identified during the study period (incidence rate-1.7 cases per 1000 persons/year). The most frequent presentation was systemic illness in 43% of cases. Of note,no patients presented with ophthalmic manifestations. The 30-days mortality was 18%. Predictors of mortality were, in the univariate analysis, admission to the intensive care unit OR 32.4 (3.65–287.06) p = 0.0001, and mechanic ventilation 84 OR (8.27–853.12) p = 0.0001, and ART OR 4.1 (0.97–17.31) p = 0.044. These variables were assessed by multivariate analysis, and only mechanical ventilation was statistically significant (p < 0.05) Conclusion: Incidence of cytomegalovirus infection was higher than described in the antiretroviral therapy era. Clinical presentation has changed. Mechanic ventilation predicted mortality.